Mirae Asset Global Investments
HAE icon

Mirae Asset Global Investments’s Haemonetics HAE Stock Holding History

Mirae Asset Global Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,302
Closed -$1.84M – 1962
2024
Q1 		$1.84M Buy
23,302
+428
+2% +$33.6K ﹤0.01% 1238
2023
Q4 		$1.96M Buy
22,874
+838
+4% +$72.4K ﹤0.01% 1269
2023
Q3 		$1.97M Sell
22,036
-2,379
-10% -$212K ﹤0.01% 1182
2023
Q2 		$2.08M Buy
24,415
+1,113
+5% +$94.1K ﹤0.01% 1195
2023
Q1 		$1.93M Buy
23,302
+1,266
+6% +$102K ﹤0.01% 1222
2022
Q4 		$1.73M Buy
22,036
+671
+3% +$53.9K ﹤0.01% 1222
2022
Q3 		$1.58M Buy
21,365
+6,460
+43% +$464K ﹤0.01% 1251
2022
Q2 		$972K Buy
+14,905
New +$882K ﹤0.01% 1420

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirae Asset Global Investments's HAE Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Haemonetics (HAE) in Q2 2024, closing a stake of 23,302 shares — an estimated $1.84M sold.

Mirae Asset Global Investments first reported a position in HAE in Q2 2022 and held it in 8 quarters. The position peaked at $2.08M in Q2 2023. 317 funds tracked by Wall St. Rank hold HAE as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Haemonetics position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 23,302 Haemonetics shares in Q2 2024, an estimated $1.84M.
  • Mirae Asset Global Investments first reported a position in Haemonetics in Q2 2022 and held it in 8 quarters.
  • Mirae Asset Global Investments's Haemonetics position peaked at $2.08M in Q2 2023.
  • 317 funds tracked by Wall St. Rank held Haemonetics as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.